The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

DENVER—A single dose of ketamine may subtly reshape how different regions of the brain communicate, a new study suggests. The research, presented June 19 at the Psychedelic Science 2025 conference, is ...

A related compound, esketamine, has been approved in the European Union and the United States for the emergency treatment of treatment-resistant depression, administered as a nasal spray under strict ...

Ketamine has been used for decades as an anaesthetic drug, but in the past few years, more and more psychiatrists have been using it for hard-to-treat depression ...

Due in part to recent reports about Matthew Perry and Elon Musk, ketamine seems to be taking up more and more space in the conversation about substance abuse. But despite its recent spike in ...

Ketamine seems to be everywhere — from the nightclub to the psychiatric clinic. Among its growing number of users is Elon Musk, who says he takes ketamine every two weeks for depression as prescribed ...

Bumetanide Nasal Spray (RSQ-777) is being developed as a convenient, outpatient-focused therapy for edema associated with congestive heart failure, as well as liver and kidney disease. “We are pleased ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for treatment-resistant depression.

The nasal spray was first approved by the FDA in 2019 as a supplemental treatment, along with an oral medication, for the approximately one-third of people with MDD who struggle with treatment ...

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression. The drug, SPRAVATO, is made by Johnson & Johnson and was first approved in 2019 for adults ...